Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Observational 7Interventional 2

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Overweight 1Obesity 1Neoplasms 1Myoma 1Myofibroma 1Leiomyoma 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Hysteroscopy × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT04748978 2021-02-15

Myolysis

University of Cagliari

Phase NA Unknown
35 enrolled

Leiomyoma, Myoma, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡